Department of Gastroenterology, First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
Department of Rheumatology, First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
J Clin Lab Anal. 2022 Feb;36(2):e24195. doi: 10.1002/jcla.24195. Epub 2021 Dec 24.
Blood group O has been reported to be a potentially protective factor for Crohn's disease (CD) susceptibility in Caucasian and Korean populations, but a similar conclusion was not found in a Chinese study. The present study investigated the potential association in the Chinese Han population.
We included 275 CD patients, 132 ulcerative colitis (UC) patients and 1201 healthy individuals in this case-control study. The demographic characteristics and ABO blood group were compared among the three groups. The clinical characteristics and treatment of CD were further investigated according to the blood group distribution.
The blood group distribution in CD patients was significantly different from healthy controls, and the frequency of O blood in CD patients was significantly lower compared to healthy controls. After adjusting for age and gender, the non-O blood groups remained significantly associated with CD susceptibility in propensity score-adjusted and propensity score-matched analyses. Compared to CD patients with non-O blood groups, patients with O blood were at a lower risk of developing penetrating disease, more likely to receive immunosuppressant treatment and less likely to receive biological treatment.
Our results confirmed that non-O blood groups were significantly associated with an increased risk of CD in the Chinese Han population.
血型 O 被报道可能是白种人和韩国人群克罗恩病(CD)易感性的保护因素,但在中国的一项研究中并未发现类似的结论。本研究旨在调查汉族人群中潜在的关联。
在这项病例对照研究中,我们纳入了 275 名 CD 患者、132 名溃疡性结肠炎(UC)患者和 1201 名健康对照者。比较了三组人群的人口统计学特征和 ABO 血型分布。进一步根据血型分布,探讨了 CD 的临床特征和治疗情况。
CD 患者的血型分布与健康对照组存在显著差异,且 O 型血在 CD 患者中的频率明显低于健康对照组。在校正年龄和性别后,非 O 血型在倾向评分调整和倾向评分匹配分析中仍与 CD 易感性显著相关。与非 O 血型的 CD 患者相比,O 血型的患者发生穿透性疾病的风险较低,更可能接受免疫抑制剂治疗,而不太可能接受生物治疗。
我们的研究结果证实,非 O 血型与中国汉族人群 CD 的发病风险增加显著相关。